- Home
- MKTW vs ANVS Comparison
MKTW vs ANVS Comparison
Compare MKTW & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTW
- ANVS
- Stock Information
- Founded
- MKTW 1999
- ANVS 2008
- Country
- MKTW United States
- ANVS United States
- Employees
- MKTW N/A
- ANVS N/A
- Industry
- MKTW Computer Software: Prepackaged Software
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- MKTW Technology
- ANVS Health Care
- Exchange
- MKTW Nasdaq
- ANVS Nasdaq
- Market Cap
- MKTW 48.2M
- ANVS 44.6M
- IPO Year
- MKTW N/A
- ANVS 2020
- Fundamental
- Price
- MKTW $20.12
- ANVS $2.36
- Analyst Decision
- MKTW
- ANVS Strong Buy
- Analyst Count
- MKTW 0
- ANVS 4
- Target Price
- MKTW N/A
- ANVS $18.00
- AVG Volume (30 Days)
- MKTW 18.2K
- ANVS 485.7K
- Earning Date
- MKTW 08-13-2025
- ANVS 08-14-2025
- Dividend Yield
- MKTW 4.00%
- ANVS N/A
- EPS Growth
- MKTW 207.28
- ANVS N/A
- EPS
- MKTW 3.12
- ANVS N/A
- Revenue
- MKTW $383,217,000.00
- ANVS N/A
- Revenue This Year
- MKTW N/A
- ANVS N/A
- Revenue Next Year
- MKTW N/A
- ANVS N/A
- P/E Ratio
- MKTW $6.40
- ANVS N/A
- Revenue Growth
- MKTW N/A
- ANVS N/A
- 52 Week Low
- MKTW $9.08
- ANVS $1.11
- 52 Week High
- MKTW $24.20
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- MKTW 64.85
- ANVS 48.29
- Support Level
- MKTW $19.21
- ANVS $2.05
- Resistance Level
- MKTW $20.12
- ANVS $3.18
- Average True Range (ATR)
- MKTW 0.80
- ANVS 0.26
- MACD
- MKTW 0.07
- ANVS -0.08
- Stochastic Oscillator
- MKTW 91.61
- ANVS 27.43
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.